-
公开(公告)号:EP4204028B1
公开(公告)日:2024-10-09
申请号:EP21799130.6
申请日:2021-08-26
CPC分类号: A61L27/46 , A61L27/52 , A61L27/54 , A61L2400/0620130101 , A61L2430/0220130101 , A61L2300/43620130101
-
公开(公告)号:EP4422707A1
公开(公告)日:2024-09-04
申请号:EP22886322.1
申请日:2022-10-27
申请人: CollPlant Ltd.
发明人: MASHIACH, Roi
IPC分类号: A61L27/14 , A61L27/38 , A61L27/50 , A61L27/52 , B29C64/124 , B29K105/00 , B33Y10/00 , B33Y70/00 , B33Y80/00
CPC分类号: A61L27/50 , B33Y10/00 , B33Y70/00 , B29C64/106 , B33Y80/00 , A61L27/26 , A61L27/58 , A61L27/54 , A61L2300/44220130101 , A61L2300/42820130101
-
公开(公告)号:EP4415771A1
公开(公告)日:2024-08-21
申请号:EP22881871.2
申请日:2022-10-17
申请人: Prohibix LLC
发明人: PURCELL, Brendan
IPC分类号: A61L27/52 , A61K31/728
CPC分类号: A61L27/52 , A61K31/728 , A61L27/20 , A61L27/58 , A61L2430/0620130101 , A61L2430/3420130101
-
4.
公开(公告)号:EP4412562A1
公开(公告)日:2024-08-14
申请号:EP22879403.8
申请日:2022-09-30
CPC分类号: A61F2/16 , A61L27/24 , A61F2002/169620150401 , A61F2002/168920130101 , A61L2430/1620130101
-
5.
公开(公告)号:EP4403196A1
公开(公告)日:2024-07-24
申请号:EP23152890.2
申请日:2023-01-23
申请人: Universität Rostock
发明人: Kussauer, Sophie , David, Robert , Polley, Christian , Seitz, Hermann , Distler, Thomas , Boccaccini, Aldo R.
CPC分类号: A61L27/26 , A61L27/3604 , A61L27/3804 , B33Y70/00 , A61L27/52
摘要: Die Erfindung betrifft in einem ersten Aspekt ein Herzschrittmacher-Konstrukt umfassend eine dreidimensionale Kernstruktur umfassend Schrittmacherzellen und Fibroblasten, in vitro hergestellt oder in vitro herstellbar mittels eines additiven Fertigungsverfahrens und/oder eines Abformverfahrens. Ein zweiter Aspekt der Erfindung bezieht sich auf ein Verfahren zur Herstellung eines Herzschrittmacher-Konstrukts, insbesondere eines Herzschrittmacher-Konstrukt gemäß des ersten Aspekts der Erfindung. Gemäß eines dritten Aspektes betrifft die Erfindung ein Herzschrittmacher-Konstrukt, erhalten oder erhältlich nach dem Verfahren des zweiten Aspektes. Ein vierter Aspekt der Erfindung bezieht sich auf die Verwendung eines Herzschrittmacher-Konstrukts gemäß des ersten Aspektes oder eines Herzschrittmacher-Konstrukts nach dem dritten Aspekt, zur Untersuchung der Auswirkung von Stoffen, insbesondere Schadstoffen und/oder Medikamenten, auf die Funktion des sinoatrialen Knotens.
-
公开(公告)号:EP4400125A1
公开(公告)日:2024-07-17
申请号:EP22867731.6
申请日:2022-09-08
申请人: Sunbio Inc.
发明人: HWANG, Seongu , KIM, Ga Eun
摘要: The present invention relates to a 6-arm PEG hydrogel composition whose physical properties are converted from a sol to a gel within 30 minutes over time.
In the present invention, two types of PEG derivatives are included as a main component of the hydrogel, and when each of the PEG derivatives is dissolved in a buffer solution, and then the two solutions are mixed, it can be converted in physical properties to a gel state within 30 minutes.-
公开(公告)号:EP3713993B1
公开(公告)日:2024-07-10
申请号:EP18810965.6
申请日:2018-11-23
IPC分类号: C08G83/00 , A61L27/52 , A61L15/44 , A61L24/00 , C08J3/075 , C08J3/24 , C08G63/91 , C08G65/333 , C08L101/00
CPC分类号: C08G83/006 , A61L27/52 , C08G83/004 , C08J3/075 , C08J3/246 , C08G65/33306 , C08L101/005 , A61L27/34 , A61L27/54 , A61L26/0066 , A61L26/008 , A61L2420/0220130101 , C08G63/672 , C08G63/916 , C08G65/3322 , C08G65/33396
-
公开(公告)号:EP4393521A1
公开(公告)日:2024-07-03
申请号:EP22866196.3
申请日:2022-06-20
发明人: WANG, Chongyu , ZHANG, Jiahui , ZHANG, Jun , LIU, Murong , HE, Chaoxian
摘要: The present application relates to the field of biotechnology, and relates to a bionic cornea and a preparation method therefor. The present application provides a bionic cornea. A raw material of the bionic cornea is pegylated collagen. The pegylated collagen comprises collagen and PEG-40k and PEG-20k which are modified on the collagen. Modifications of PEG-40k and PEG-20k can significantly improve the cross-linking performance of the collagen, so that the strength of the cornea of the present application is increased by nearly 20 times compared with the strength of the cornea prepared from collagen, and is increased by nearly 12 times compared with the strength of the cornea prepared from the existing another pegylated collagen. Therefore, the cornea of the present application has good application prospect in the field of corneal transplantation. A molar ratio of PEG-40k to PEG-20k is 2-3:1. The effect of improving the cross-linking performance of the collagen by PEG modification at this molar ratio is better, and the strength of the cornea of the present application can be further improved.
-
公开(公告)号:EP4392086A1
公开(公告)日:2024-07-03
申请号:EP22862289.0
申请日:2022-08-26
CPC分类号: A61L27/52 , C12M25/14 , C12N5/0693 , C12N2537/1020130101 , C12N2500/5020130101 , A61L27/18 , A61L27/3804 , A61L2300/25220130101
-
公开(公告)号:EP4013463B1
公开(公告)日:2024-06-26
申请号:EP20768414.3
申请日:2020-08-12
IPC分类号: A61L27/14 , A61L27/38 , A61L27/56 , A61L27/16 , A61L27/18 , A61L27/20 , A61L27/22 , A61L27/34 , A61L27/50 , A61L27/52
CPC分类号: A61L27/14 , A61L27/56 , A61L2400/1220130101 , A61L2430/3420130101 , A61L2430/1220130101 , A61L27/52 , A61L27/34 , A61L27/50
-
-
-
-
-
-
-
-
-